deaths from glp 1 GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality in T2D with acute kidney disease Risk of all–cause death and

The researchers found major aberrations in ROS clearance pathways, noting that Long COVID patients showed significantly lower levels of mitochondrial superoxide dismutase 2 (SOD2), a highly protective enzyme

Ind J Clin Biochem (2026)

This class of medications sounds pretty new because the excitement surrounding the drugs (and celeb interest) has exploded in recent years, but GLP-1s have been around for 20 years

Why Researchers Source the BPC-157 / TB-500 Blend from LiveWell Peptides LiveWell Peptides is a US-based cGMP peptide manufacturer headquartered in Dallas, Texas , supplying research-grade peptides and peptide blends to laboratories, universities and qualified independent researchers across the United States and internationally

While GLP1 medications are not currently an ADHD treatment, the research and patient experiences around them point to something important: women with ADHD deserve care that looks beyond attention and focus alone

At the same time, regulatory changes could restrict availability or increase costs for certain peptides